TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.76M | 1.05M | 2.44M | 1.72M | 783.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.73M | 5.98M | 7.02M | 5.69M | 3.73M |
| Operating Income | -6.73M | -5.98M | -7.02M | -5.69M | -3.73M |
| Income Before Tax | -7.10M | -9.52M | -6.66M | -6.00M | -5.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.10M | -9.52M | -6.66M | -6.00M | -5.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.10M | -9.52M | -6.66M | -6.00M | -5.58M |
| EBIT | -6.73M | -5.98M | -7.02M | -5.69M | -3.73M |
| EBITDA | -6.71M | -5.96M | -7.00M | -5.68M | -3.70M |
| EPS Basic | -0.14 | -0.21 | -0.15 | -0.14 | -0.54 |
| Normalized Basic EPS | -0.09 | -0.08 | -0.10 | -0.09 | -0.29 |
| EPS Diluted | -0.14 | -0.21 | -0.15 | -0.14 | -0.54 |
| Normalized Diluted EPS | -0.09 | -0.08 | -0.10 | -0.09 | -0.29 |
| Average Basic Shares Outstanding | 50.67M | 44.56M | 43.40M | 42.32M | 12.18M |
| Average Diluted Shares Outstanding | 50.67M | 44.56M | 43.40M | 42.32M | 12.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.03% | -0.02% | -0.03% | -- | -- |